Skip to main content
Erschienen in: World Journal of Surgery 1/2012

01.01.2012

Estimating the Need for Neck Lymphadenectomy in Submucosal Esophageal Cancer Using Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging: Clinical Validation Study

verfasst von: Satoru Motoyama, Koichi Ishiyama, Kiyotomi Maruyama, Komei Narita, Yoshihiro Minamiya, Jun-ichi Ogawa

Erschienen in: World Journal of Surgery | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

In cases of thoracic esophageal cancer, multidirectional lymphatic flow from the tumor means that lymph node metastasis can occur in an area extending from the neck to the abdomen. To validate a method for limiting the performance of three-field lymphadenectomy only to patients who need it, we carried out a prospective study in which superparamagnetic iron oxide (SPIO)-enhanced lymphatic mapping was used to determine whether to perform neck lymph node dissection in patients with submucosal thoracic esophageal cancer.

Methods

A total of 22 patients with clinically submucosal thoracic squamous cell esophageal cancer, without neck lymph node metastasis, were enrolled. SPIO was endoscopically injected into the peritumoral submucosal layer, after which its appearance in lymph nodes in the neck was evaluated using magnetic resonance imaging (MRI). Neck lymph nodes were then dissected based on the SPIO-enhanced MRI lymphatic mapping.

Results

Influx of SPIO into lymph nodes was detected in 21 patients (95% detection rate). SPIO flowed to the neck in 8 (36%) patients. Influx of SPIO into neck lymph nodes was unilateral in five patients and bilateral in three patients, and the lymph nodes were dissected accordingly. A cancer-involved node was identified in two of those patients. In 14 patients, we did not dissect neck nodes. Patients were followed up for 6 to 47 months. The neck lymph node recurrence rate was zero, and the overall recurrence rate was 5%.

Conclusions

SPIO-enhanced lymphatic mapping may be useful for estimating the need for three-field lymphadenectomy with neck dissection.
Literatur
1.
Zurück zum Zitat Shimada H, Okazumi S, Matsubara H et al (2006) Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 30:1441–1449. doi:10.1007/s00268-005-0462-6 PubMedCrossRef Shimada H, Okazumi S, Matsubara H et al (2006) Impact of the number and extent of positive lymph nodes in 200 patients with thoracic esophageal squamous cell carcinoma after three-field lymph node dissection. World J Surg 30:1441–1449. doi:10.​1007/​s00268-005-0462-6 PubMedCrossRef
2.
Zurück zum Zitat Xu QR, Zhuge XP, Zhang HL et al (2011) The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis? World J Surg 35:1303–1310. doi:10.1007/s00268-011-1015-9 PubMedCrossRef Xu QR, Zhuge XP, Zhang HL et al (2011) The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis? World J Surg 35:1303–1310. doi:10.​1007/​s00268-011-1015-9 PubMedCrossRef
3.
Zurück zum Zitat Jamieson GG, Thompson SK (2009) Detection of lymph node metastases in oesophageal cancer. Br J Surg 96:21–25PubMedCrossRef Jamieson GG, Thompson SK (2009) Detection of lymph node metastases in oesophageal cancer. Br J Surg 96:21–25PubMedCrossRef
4.
Zurück zum Zitat Tsurumaru M, Kajiyama Y, Udagawa H et al (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7:325–329PubMed Tsurumaru M, Kajiyama Y, Udagawa H et al (2001) Outcomes of extended lymph node dissection for squamous cell carcinoma of the thoracic esophagus. Ann Thorac Cardiovasc Surg 7:325–329PubMed
5.
Zurück zum Zitat Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239:483–490PubMedCrossRef Igaki H, Tachimori Y, Kato H (2004) Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg 239:483–490PubMedCrossRef
6.
Zurück zum Zitat Law S, Wong J (2001) Two-field dissection is enough for esophageal cancer. Dis Esophagus 14:98–103PubMedCrossRef Law S, Wong J (2001) Two-field dissection is enough for esophageal cancer. Dis Esophagus 14:98–103PubMedCrossRef
7.
Zurück zum Zitat Pennathur A, Zhang J, Chen H et al (2010) The “best operation” for esophageal cancer? Ann Thorac Surg 89:S2163–S2167PubMedCrossRef Pennathur A, Zhang J, Chen H et al (2010) The “best operation” for esophageal cancer? Ann Thorac Surg 89:S2163–S2167PubMedCrossRef
8.
Zurück zum Zitat Altorki NK (2006) Lymph node dissection for carcinoma of the esophagus, In: Difficult Decisions in Thoracic Surgery: An Evidence-based Approach. Springer-Verlag, London, pp 225–233 Altorki NK (2006) Lymph node dissection for carcinoma of the esophagus, In: Difficult Decisions in Thoracic Surgery: An Evidence-based Approach. Springer-Verlag, London, pp 225–233
9.
Zurück zum Zitat Motoyama S, Ishiyama K, Maruyama K et al (2007) Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer. Surgery 141:736–747PubMedCrossRef Motoyama S, Ishiyama K, Maruyama K et al (2007) Preoperative mapping of lymphatic drainage from the tumor using ferumoxide-enhanced magnetic resonance imaging in clinical submucosal thoracic squamous cell esophageal cancer. Surgery 141:736–747PubMedCrossRef
10.
Zurück zum Zitat Ishiyama K, Motoyama S, Tomura N et al (2006) Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer. J Comput Assist Tomogr 30:270–275PubMedCrossRef Ishiyama K, Motoyama S, Tomura N et al (2006) Visualization of lymphatic basin from the tumor using magnetic resonance lymphography with superparamagnetic iron oxide in patients with thoracic esophageal cancer. J Comput Assist Tomogr 30:270–275PubMedCrossRef
11.
Zurück zum Zitat Saini S, Stark DD, Hahn PF et al (1987) Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162:211–216PubMed Saini S, Stark DD, Hahn PF et al (1987) Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology 162:211–216PubMed
12.
Zurück zum Zitat Motoyama S, Saito R, Kitamura M et al (2003) Outcome of active surgery during intensive follow-up for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma. J Am Coll Surg 197:914–920PubMedCrossRef Motoyama S, Saito R, Kitamura M et al (2003) Outcome of active surgery during intensive follow-up for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma. J Am Coll Surg 197:914–920PubMedCrossRef
13.
Zurück zum Zitat Japan Society for Esophageal Diseases (2004) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: preface, general principles, part I. Esophagus 1:61–88 Japan Society for Esophageal Diseases (2004) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, ninth edition: preface, general principles, part I. Esophagus 1:61–88
14.
Zurück zum Zitat Ando N, Ozawa S, Kitagawa Y et al (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232PubMedCrossRef Ando N, Ozawa S, Kitagawa Y et al (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232PubMedCrossRef
15.
Zurück zum Zitat Motoyama S, Maruyama K, Sato Y et al (2009) Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and T2–4 thoracic squamous cell esophageal cancers. World J Surg 33:512–517. doi:10.1007/s00268-008-9781-8 PubMedCrossRef Motoyama S, Maruyama K, Sato Y et al (2009) Status of involved lymph nodes and direction of metastatic lymphatic flow between submucosal and T2–4 thoracic squamous cell esophageal cancers. World J Surg 33:512–517. doi:10.​1007/​s00268-008-9781-8 PubMedCrossRef
16.
Zurück zum Zitat Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399PubMedCrossRef Morton DL, Wen DR, Wong JH et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399PubMedCrossRef
17.
Zurück zum Zitat Kitagawa Y, Fujii H, Mukai M et al (2002) Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am 11:293–304PubMedCrossRef Kitagawa Y, Fujii H, Mukai M et al (2002) Intraoperative lymphatic mapping and sentinel lymph node sampling in esophageal and gastric cancer. Surg Oncol Clin N Am 11:293–304PubMedCrossRef
18.
Zurück zum Zitat Takeuchi H, Fujii H, Ando N et al (2009) Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 249:757–763PubMedCrossRef Takeuchi H, Fujii H, Ando N et al (2009) Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg 249:757–763PubMedCrossRef
19.
Zurück zum Zitat Imano H, Motoyama S, Saito R et al (2004) Superior mediastinal and neck lymphatic mapping in mid- and lower-thoracic esophageal cancer as defined by ferumoxide-enhanced magnetic resonance imaging. Jpn J Thorac Cardiovasc Surg 52:445–450PubMedCrossRef Imano H, Motoyama S, Saito R et al (2004) Superior mediastinal and neck lymphatic mapping in mid- and lower-thoracic esophageal cancer as defined by ferumoxide-enhanced magnetic resonance imaging. Jpn J Thorac Cardiovasc Surg 52:445–450PubMedCrossRef
20.
Zurück zum Zitat Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3)N(any)M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–433PubMedCrossRef Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2–3)N(any)M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425–433PubMedCrossRef
Metadaten
Titel
Estimating the Need for Neck Lymphadenectomy in Submucosal Esophageal Cancer Using Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging: Clinical Validation Study
verfasst von
Satoru Motoyama
Koichi Ishiyama
Kiyotomi Maruyama
Komei Narita
Yoshihiro Minamiya
Jun-ichi Ogawa
Publikationsdatum
01.01.2012
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 1/2012
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-011-1322-1

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgery 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.